In The News
10 diabetes drugs Bay Area biotech companies have in the pipeline
BRIEF-Tonghua Dongbao Pharmaceutical signs new agreement on establishment of biomedicine JV
Oct 24 (Reuters) – Tonghua Dongbao Pharmaceutical Co Ltd :
* Says it terminates former agreement with Harmony Biopharm Ltd and a Shanghai-based biomedicine firm, and signed a new one with Dance Biopharm Holding Inc and the Shanghai-based biomedicine firm, to set up a new biomedicine JV with registered capital of 102.6 million yuan
* Co will invest 46.2 million yuan and will own a 45 percent stake in JV
Source text in Chinese: goo.gl/T6HBeu